glp-1 compounding crackdown news october 2025 FDA regulators, customs officers, and physicians around the world are continuing to raise alarms about unsafe and unregulated weight-loss and peptide products. An FDA warning letter to ProRx states the company continued FDA cracks down on 'misleading'

He's a professor at the Department of Biomedical Sciences at the University of Copenhagen in Denmark, and he's won several of the world's most prestigious awards in science, including the 2020 Warren Alpert Foundation Prize and the 2021 Canada Gairdner International Awards and the 2025 Breakthrough Prize in Life Sciences, and he shared the Alpert Prize, by the way, with other scientists in the United States as well

Naltrexone is an opioid antagonist, meaning it blocks the effects of opioids and can trigger sudden, severe withdrawal symptoms in people who are physically dependent on them

Instead of worrying about the number you are seeing on the scale, note other positive changes in your body after weight training such as increased strength, improved energy, and a leaner body shape

publication) reviewed the medical literature for studies that looked at the connection between GLP-1 drugs associated with delayed gastric emptying (like Ozempic) and the risk of pulmonary aspiration during the "peri-operative" time period (before

Centrally-acting appetite suppressants These act on the brains appetite and reward systems to reduce hunger and cravings